High TCP1 expression was discovered in cisplatin-resistant ovarian cancer cell lines and the reducing TCP1 expression incremented cisplatin-induced apoptosis and the sensitivity of the cells to cisplatin as well [11], whereas, to date, the TCP1 role in leukemia remains unreported. This evidence concerns the gene TCP1 and ovarian carcinoma.